MEDACTA GROUP SA

News Medacta Group SA

Equities

MOVE

CH0468525222

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange Other stock markets 11:31:38 2024-12-04 am EST			5-day change	1st Jan Change
110.20 ^CHF	+2.04%		-0.90%	-12.26%

Sep. 25	Swiss Market Index Advances Ahead of SNB's Rate Decision Day	MT
Sep. 25	Medacta Group SA - Analyst/Investor Day

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Medacta : Announces First Anatomic Shoulder Replacement with the NextAR Augmented Reality Surgical Application in the United States	Nov. 28	PU
Medacta : Geisinger, Medacta announce first shoulder replacement with lifetime guarantee	Nov. 22	PU
Medacta : appoints new Group VP Investor & Financial Media Relations & ESG	Nov. 21	PU
Medacta : Unveiling of GMK SpheriKA Continues Across Europe, Featuring Innovative Personalized Solutions at SIOT 2024 in Italy	Nov. 13	PU
Medacta unveils the extended enhancements to its Hip Revision Platform	Oct. 21	EQ
Medacta : unveils the extended enhancements to its Hip Revision Platform	Oct. 21	PU
Medacta Hosts Inaugural Capital Markets Day, Showcasing Responsible Innovation and Effective Growth Strategy	Sep. 30	EQ
Medacta : to Feature GMK SpheriKA and Innovative Personalized Solutions at AAOS 2024	Sep. 26	PU
Swiss Market Index Advances Ahead of SNB's Rate Decision Day	Sep. 25	MT
Medacta Group SA - Analyst/Investor Day	Sep. 25
Medacta Group Reports Growth in H1 Attributable Profit, Revenue	Sep. 25	MT
Medacta : 2024 Half-Year Report	Sep. 25	PU
Medacta : 2024 Half-Year Presentation	Sep. 25	PU
Medacta Group SA reports revenue growth of 14.3% at constant currency and adjusted EBITDA margin 26.9%, or 28.1% at constant currency in 1H 2024.	Sep. 25	EQ
Medacta NextAR Rod Optimizer, a Disruptive Technology Redefining Rod Management in Spine Surgery, wins the 2024 Spine Technology Award from Orthopedics This Week	Sep. 24	EQ
Medacta's Profitability at Risk Amid Expected Sales Slowdown in H1, Morgan Stanley Says	Sep. 24	MT
Medacta Group SA Reports Earnings Results for the Half Year Ended June 30, 2024	Sep. 23	CI
Medacta Introduces a Simplified Approach for the M-ARS ACL Technique at the AGA Congress 2024, Mimicking the Native Ligament Footprint with an Optimized Surgical Flow	Sep. 12	EQ
THINK Surgical Receives FDA 510(k) Clearance for Medacta GMK Sphere and SpheriKA implants on TMINI Miniature Robotic System	Aug. 30	AQ
Medacta Group, Think Surgical Partner in US for Robotic Total Knee Arthroplasty Solution	Aug. 30	MT
Medacta Enters Partnership with THINK Surgical for Robotic Total Knee Arthroplasty Solution	Aug. 29	EQ
Medacta Group, Mighty Oak Medical Settle Patent Dispute via New License Deal	Aug. 28	MT
Mighty Oak Medical and Medacta Announce Non-Exclusive Worldwide License of Patents for Patient-Specific Pedicle Screw Guides	Aug. 28	EQ
Medacta Group SA, H1 2024 Earnings Call, Jul 25, 2024	Jul. 25
Medacta Group SA: Medacta Group SA revenues grew 14.3% at constant currency in 1H 2024	Jul. 24	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
MOVE Stock
News Medacta Group SA

Exceptional Extension | BLACK FRIDAY -40% : Unlock Tomorrow's Top Investments with Our Exclusive Subscriber-Only Tools!

BENEFIT NOW